Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon B Mills

Showing results (181-190 of 826) with videos related to

Pageof 83
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|January 11, 2011
Polymorphisms in the SULF1 gene are associated with early age of onset and survival of ovarian cancerChan H Han, Yu-Jing Huang, Karen H Lu, et al.
Cancer Discovery|April 21, 2026
scSurvival: Single-Cell Survival Analysis of Clinical Cancer Cohort Data at Cellular ResolutionTao Ren, Faming Zhao, Canping Chen, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
miniMTI: minimal multiplex tissue imaging enhances biomarker expression prediction from histologyZachary Sims, Sandhya Govindarajan, Kaoutar Ait-Ahmad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2014
Reverse-phase protein array profiling of oropharyngeal cancer and significance of PIK3CA mutations in HPV-associated head and neck cancerAndrew Sewell, Brandee Brown, Asel Biktasova, et al.
The Journal of Biological Chemistry|October 7, 2004
Glycogen synthase kinase 3beta is a negative regulator of growth factor-induced activation of the c-Jun N-terminal kinaseShuying Liu, Shuangxing Yu, Yutaka Hasegawa, et al.
Advances in Experimental Medicine and Biology|December 11, 2019
Using Reverse Phase Protein Array (RPPA) to Identify and Target Adaptive ResistanceMarilyne Labrie, Yong Fang, Nicholas D Kendsersky, et al.
Journal of Oncology|December 29, 2009
Targeting the epidermal growth factor receptor in epithelial ovarian cancer: current knowledge and future challengesDoris R Siwak, Mark Carey, Bryan T Hennessy, et al.
NPJ Breast Cancer|August 3, 2019
The phosphatase PPM1A inhibits triple negative breast cancer growth by blocking cell cycle progressionAbhijit Mazumdar, William M Tahaney, Lakshmi Reddy Bollu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2009
Combined Src and aromatase inhibition impairs human breast cancer growth in vivo and bypass pathways are activated in AZD0530-resistant tumorsYi Chen, Natalia Guggisberg, Merce Jorda, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 11, 2017
CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrenceKatherine C Kurnit, Grace N Kim, Bryan M Fellman, et al.
Pageof 83

Showing results (181-190 of 826) with videos related to

Sort By:
Pageof 83
Journal of Experimental & Clinical Cancer Research : CR|January 11, 2011
Polymorphisms in the SULF1 gene are associated with early age of onset and survival of ovarian cancerChan H Han, Yu-Jing Huang, Karen H Lu, et al.
Cancer Discovery|April 21, 2026
scSurvival: Single-Cell Survival Analysis of Clinical Cancer Cohort Data at Cellular ResolutionTao Ren, Faming Zhao, Canping Chen, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
miniMTI: minimal multiplex tissue imaging enhances biomarker expression prediction from histologyZachary Sims, Sandhya Govindarajan, Kaoutar Ait-Ahmad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2014
Reverse-phase protein array profiling of oropharyngeal cancer and significance of PIK3CA mutations in HPV-associated head and neck cancerAndrew Sewell, Brandee Brown, Asel Biktasova, et al.
The Journal of Biological Chemistry|October 7, 2004
Glycogen synthase kinase 3beta is a negative regulator of growth factor-induced activation of the c-Jun N-terminal kinaseShuying Liu, Shuangxing Yu, Yutaka Hasegawa, et al.
Advances in Experimental Medicine and Biology|December 11, 2019
Using Reverse Phase Protein Array (RPPA) to Identify and Target Adaptive ResistanceMarilyne Labrie, Yong Fang, Nicholas D Kendsersky, et al.
Journal of Oncology|December 29, 2009
Targeting the epidermal growth factor receptor in epithelial ovarian cancer: current knowledge and future challengesDoris R Siwak, Mark Carey, Bryan T Hennessy, et al.
NPJ Breast Cancer|August 3, 2019
The phosphatase PPM1A inhibits triple negative breast cancer growth by blocking cell cycle progressionAbhijit Mazumdar, William M Tahaney, Lakshmi Reddy Bollu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2009
Combined Src and aromatase inhibition impairs human breast cancer growth in vivo and bypass pathways are activated in AZD0530-resistant tumorsYi Chen, Natalia Guggisberg, Merce Jorda, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 11, 2017
CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrenceKatherine C Kurnit, Grace N Kim, Bryan M Fellman, et al.
Pageof 83